Holdings

NEXTBio Capital Management LP

As of Sep 30, 2026, NEXTBio Capital Management LP reported 22 positions worth US$208M. Largest: Protagonist Therapeutics, Inc., Shattuck Labs, Inc. and COMPASS Pathways Plc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Protagonist Therapeutics, Inc.219KUS$30.9Mno changeSep 30, 2026
Shattuck Labs, Inc.3.73MUS$25.4Mno changeSep 30, 2026
COMPASS Pathways Plc1.78MUS$22.1MnewSep 30, 2026
Rhythm Pharmaceuticals, Inc.132KUS$12.5Mno changeSep 30, 2026
Vor Biopharma Inc.621KUS$11.8M−268KSep 30, 2026
Xenon Pharmaceuticals Inc.310KUS$11.5M+127KSep 30, 2026
Zenas BioPharma, Inc.427KUS$11.5Mno changeSep 30, 2026
Palvella Therapeutics, Inc.80,409US$11.1M−9,500Sep 30, 2026
Structure Therapeutics, Inc.312KUS$9.77MnewSep 30, 2026
ORIC Pharmaceuticals, Inc.684KUS$9.22M−21,648Sep 30, 2026